Lopman BA[au] - Search Results

Year	Number of Results
1998	1
1999	1
2000	1
2001	1
2002	1
2003	7
2004	6
2005	3
2006	4
2007	2
2008	2
2009	6
2010	2
2011	9
2012	12
2013	10
2014	9
2015	9
2016	9
2017	7
2018	12
2019	8
2020	16
2021	28
2022	14

1

Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines.

Lewnard JA, Patel MM, Jewell NP, Verani JR, Kobayashi M, Tenforde MW, Dean NE, Cowling BJ, Lopman BA. Lewnard JA, et al. Among authors: lopman ba. Epidemiology. 2021 Jul 1;32(4):508-517. doi: 10.1097/EDE.0000000000001366. Epidemiology. 2021. PMID: 34001753 Free PMC article. Review.

2

Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis.

Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P, Parashar UD, Koopmans M, Lopman BA. Ahmed SM, et al. Among authors: lopman ba. Lancet Infect Dis. 2014 Aug;14(8):725-730. doi: 10.1016/S1473-3099(14)70767-4. Epub 2014 Jun 26. Lancet Infect Dis. 2014. PMID: 24981041 Free PMC article. Review.

3

Waxing Understanding of Waning Immunity.

Lopman BA, Pitzer VE. Lopman BA, et al. J Infect Dis. 2018 Mar 5;217(6):851-853. doi: 10.1093/infdis/jix670. J Infect Dis. 2018. PMID: 29394364 Free PMC article. No abstract available.

4

Wading Into the Morass: Natural Immunity to Enteropathogens.

Lopman BA, Baker JM. Lopman BA, et al. J Infect Dis. 2020 Nov 9;222(11):1764-1767. doi: 10.1093/infdis/jiaa033. J Infect Dis. 2020. PMID: 31985004 Free PMC article. No abstract available.

5

Population immunity and vaccine protection against infection.

Leshem E, Lopman BA. Leshem E, et al. Among authors: lopman ba. Lancet. 2021 May 8;397(10286):1685-1687. doi: 10.1016/S0140-6736(21)00870-9. Epub 2021 Apr 23. Lancet. 2021. PMID: 33901422 Free PMC article. No abstract available.

6

Using viral load to model disease dynamics.

Lopman BA, McQuade ETR. Lopman BA, et al. Science. 2021 Jul 16;373(6552):280-281. doi: 10.1126/science.abj4185. Science. 2021. PMID: 34437141 No abstract available.

7

A framework for monitoring population immunity to SARS-CoV-2.

Lopman BA, Shioda K, Nguyen Q, Beckett SJ, Siegler AJ, Sullivan PS, Weitz JS. Lopman BA, et al. Ann Epidemiol. 2021 Nov;63:75-78. doi: 10.1016/j.annepidem.2021.08.013. Epub 2021 Aug 21. Ann Epidemiol. 2021. PMID: 34425208 Free PMC article.

8

Severe breakthrough COVID-19 infections in Scotland-implications for immunisation programmes.

Leshem E, Nelson K, Lopman BA. Leshem E, et al. Among authors: lopman ba. Lancet Respir Med. 2021 Dec;9(12):1354-1356. doi: 10.1016/S2213-2600(21)00413-6. Epub 2021 Sep 29. Lancet Respir Med. 2021. PMID: 34599904 Free PMC article. No abstract available.

9

Cost-effectiveness of pediatric norovirus vaccination in daycare settings.

Steimle LN, Havumaki J, Eisenberg MC, Eisenberg JNS, Prosser LA, Pike J, Ortega-Sanchez IR, Mattison CP, Hall AJ, Steele MK, Lopman BA, Hutton DW. Steimle LN, et al. Among authors: lopman ba. Vaccine. 2021 Apr 8;39(15):2133-2145. doi: 10.1016/j.vaccine.2021.02.066. Epub 2021 Mar 23. Vaccine. 2021. PMID: 33741192 Free PMC article.

10

Causes of impaired oral vaccine efficacy in developing countries.

Parker EP, Ramani S, Lopman BA, Church JA, Iturriza-Gómara M, Prendergast AJ, Grassly NC. Parker EP, et al. Among authors: lopman ba. Future Microbiol. 2018 Jan;13(1):97-118. doi: 10.2217/fmb-2017-0128. Epub 2017 Dec 8. Future Microbiol. 2018. PMID: 29218997 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results